These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 28003667)

  • 1. Urinary Cross-linked N-terminal Telopeptide of Type I Collagen Levels of Infants with Osteogenesis Imperfecta and Healthy Infants.
    Yamashita M; Hasegawa K; Higuchi Y; Miyai T; Okada A; Tanaka H; Tsukahara H
    Acta Med Okayama; 2016 Dec; 70(6):435-439. PubMed ID: 28003667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired pyridinoline cross-link formation in patients with osteogenesis imperfecta.
    Hasegawa K; Kataoka K; Inoue M; Seino Y; Morishima T; Tanaka H
    J Bone Miner Metab; 2008; 26(4):394-9. PubMed ID: 18600407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of urinary and serum cross-linked N-telopeptide of type I collagen (NTx) for diagnosis of bone metastasis in patients with lung cancer.
    Tamiya M; Tokunaga S; Okada H; Suzuki H; Kobayashi M; Sasada S; Okamoto N; Morishita N; Matsuura Y; Miyamoto N; Hattori M; Taira K; Daga H; Takeda K; Hirashima T
    Clin Lung Cancer; 2013 Jul; 14(4):364-9. PubMed ID: 23276824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased cartilage type II collagen degradation in patients with osteogenesis imperfecta used as a human model of bone type I collagen alterations.
    Rousseau JC; Chevrel G; Schott AM; Garnero P
    Bone; 2010 Apr; 46(4):897-900. PubMed ID: 20005316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss].
    Liu SP; Liao EY; Wu XP; Cao XZ; Shan PF; Su X
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):371-5. PubMed ID: 16677543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteogenesis imperfecta types I, III, and IV: effect of pamidronate therapy on bone and mineral metabolism.
    Rauch F; Plotkin H; Travers R; Zeitlin L; Glorieux FH
    J Clin Endocrinol Metab; 2003 Mar; 88(3):986-92. PubMed ID: 12629073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutations.
    Garnero P; Schott AM; Prockop D; Chevrel G
    Bone; 2009 Mar; 44(3):461-6. PubMed ID: 19071236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone turnover markers in patients with osteogenesis imperfecta.
    Braga V; Gatti D; Rossini M; Colapietro F; Battaglia E; Viapiana O; Adami S
    Bone; 2004 Jun; 34(6):1013-6. PubMed ID: 15193547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates.
    Fizazi K; Lipton A; Mariette X; Body JJ; Rahim Y; Gralow JR; Gao G; Wu L; Sohn W; Jun S
    J Clin Oncol; 2009 Apr; 27(10):1564-71. PubMed ID: 19237632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone resorption in stroke and institutionalized subjects.
    Haddaway MJ; Bainbridge NJ; Powell DE; Davie MW
    Calcif Tissue Int; 2009 Feb; 84(2):118-25. PubMed ID: 19142679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum 24,25-dihydroxyvitamin D concentrations in osteogenesis imperfecta: relationship to bone parameters.
    Edouard T; Husseini A; Glorieux FH; Rauch F
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1243-9. PubMed ID: 22319032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher bone resorption excretion in South Asian women vs. White Caucasians and increased bone loss with higher seasonal cycling of vitamin D: Results from the D-FINES cohort study.
    Darling AL; Hart KH; Gossiel F; Robertson F; Hunt J; Hill TR; Johnsen S; Berry JL; Eastell R; Vieth R; Lanham-New SA
    Bone; 2017 May; 98():47-53. PubMed ID: 28286239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone resorption assessed by immunoassay of urinary cross-linked collagen peptides in patients with osteogenesis imperfecta.
    Brenner RE; Vetter U; Bollen AM; Mörike M; Eyre DR
    J Bone Miner Res; 1994 Jul; 9(7):993-7. PubMed ID: 7942168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collagen-derived markers of bone metabolism in osteogenesis imperfecta.
    Lund AM; Hansen M; Kollerup G; Juul A; Teisner B; Skovby F
    Acta Paediatr; 1998 Nov; 87(11):1131-7. PubMed ID: 9846914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary excretion of cross-linked N-telopeptides of type 1 collagen to assess bone resorption in infants from birth to 1 year of age.
    Lapillonne A; Travers R; DiMaio M; Salle BL; Glorieux FH
    Pediatrics; 2002 Jul; 110(1 Pt 1):105-9. PubMed ID: 12093954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type V osteogenesis imperfecta: a new form of brittle bone disease.
    Glorieux FH; Rauch F; Plotkin H; Ward L; Travers R; Roughley P; Lalic L; Glorieux DF; Fassier F; Bishop NJ
    J Bone Miner Res; 2000 Sep; 15(9):1650-8. PubMed ID: 10976985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change of cross-linked telopeptide of type I collagen (ICTP) and other bone resorption markers in patients with bone fragility fractures.
    Takahara K; Kamimura M; Hashidate H; Uchiyama S; Nakagawa H
    J Orthop Sci; 2007 May; 12(3):219-26. PubMed ID: 17530373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biochemical markers of bone turnover. New aspect. Metabolic bone markers in osteogenesis imperfecta].
    Tanaka H
    Clin Calcium; 2009 Aug; 19(8):1142-7. PubMed ID: 19638698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A light and electron microscopic study of osteogenesis imperfecta bone samples, with reference to collagen chemistry and clinical phenotype.
    Sarathchandra P; Pope FM; Kayser MV; Ali SY
    J Pathol; 2000 Nov; 192(3):385-95. PubMed ID: 11054723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect.
    Glorieux FH; Ward LM; Rauch F; Lalic L; Roughley PJ; Travers R
    J Bone Miner Res; 2002 Jan; 17(1):30-8. PubMed ID: 11771667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.